FutureChem Co.,Ltd (KOSDAQ:220100)
18,580
-190 (-1.01%)
Sep 19, 2025, 3:30 PM KST
FutureChem Co.,Ltd Revenue
FutureChem Co.,Ltd had revenue of 3.64B KRW in the quarter ending June 30, 2025, with 6.02% growth. This brings the company's revenue in the last twelve months to 19.14B, up 28.30% year-over-year. In the year 2024, FutureChem Co.,Ltd had annual revenue of 17.29B with 23.81% growth.
Revenue (ttm)
19.14B
Revenue Growth
+28.30%
P/S Ratio
21.45
Revenue / Employee
285.69M
Employees
67
Market Cap
410.56B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 17.29B | 3.33B | 23.81% |
Dec 31, 2023 | 13.97B | 1.39B | 11.09% |
Dec 31, 2022 | 12.57B | 755.26M | 6.39% |
Dec 31, 2021 | 11.82B | 805.07M | 7.31% |
Dec 31, 2020 | 11.01B | 2.85B | 34.86% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
ABL Bio | 94.93B |